Pure Global
CDSCO UID IMP/IVD/2021/000365_9af47ee0c5f4d523156cb00c9b724b22_d0a38addf0234cb75b9f9c3fb9aa194d

PRL

BODITECH MED INDIA PRIVATE LIMITED·Device Class Class B·India CDSCO·Brand: AFIAS Infliximab
Registration details
UID
IMP/IVD/2021/000365_9af47ee0c5f4d523156cb00c9b724b22_d0a38addf0234cb75b9f9c3fb9aa194d
Device class
Class B
Brand name
AFIAS Infliximab
License holder
BODITECH MED INDIA PRIVATE LIMITED
Approving authority
CDSCO
Product information
AFIAS PRL is a fluorescence Immunoassay (AFIAS Infliximab ) for the quantitative determination of Prolactin (AFIAS Infliximab ) in human whole blood/serum/plasma. It is useful as an aid in management and monitoring of hypothalamic-pituitary disorders
Similar products (10)
Other products with the same name or brand
PRL
M/s Vishat Diagnostic Pvt Ltd.
Class B
PRL
Brand: ichroma™ Myoglobin neo
CPC DIAGNOSTICS PVT.LTD
Class B
PRL
Brand: ichroma™ Myoglobin neo
CPC DIAGNOSTICS PVT.LTD
Class B
TSH
Brand: AFIAS Infliximab
BODITECH MED INDIA PRIVATE LIMITED
Class B
Progesterone
Brand: AFIAS Infliximab
BODITECH MED INDIA PRIVATE LIMITED
Class B
Myoglobin
Brand: AFIAS Infliximab
BODITECH MED INDIA PRIVATE LIMITED
Class B
AMH
Brand: AFIAS Infliximab
BODITECH MED INDIA PRIVATE LIMITED
Class B
Testosterone
Brand: AFIAS Infliximab
BODITECH MED INDIA PRIVATE LIMITED
Class B
IL-6
Brand: AFIAS Infliximab
BODITECH MED INDIA PRIVATE LIMITED
Class B
AFIAS Total Anti-Infliximab
Brand: AFIAS Infliximab
BODITECH MED INDIA PRIVATE LIMITED
Class B
Other products from BODITECH MED INDIA PRIVATE LIMITED
Products from the same license holder (10 products)
TSH
Brand: AFIAS Infliximab
Class B
Progesterone
Brand: AFIAS Infliximab
Class B
AFIAS-6
Brand: AFIAS-10
Class A
Myoglobin
Brand: AFIAS Infliximab
Class B
AMH
Brand: AFIAS Infliximab
Class B
Testosterone
Brand: AFIAS Infliximab
Class B
IL-6
Brand: AFIAS Infliximab
Class B
Cardiac Triple
Brand: AFIAS ST2
Class C
AFIAS Total Anti-Infliximab
Brand: AFIAS Infliximab
Class B
AFIAS NORO
Brand: AFIAS ST2
Class C
About this record

PRL is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000365_9af47ee0c5f4d523156cb00c9b724b22_d0a38addf0234cb75b9f9c3fb9aa194d. This device is marketed under the brand name AFIAS Infliximab . The license holder is BODITECH MED INDIA PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.